This has specific relevance to gastrointestinal disorders, as elevated levels of faecal TYR were identified as a differential biomarker in patients with inflammatory bowel disease in a cross-sectional study [52] and TYR has demonstrated cellular cytotoxicity at high doses [37,66]. This evidence concerns the gene TYR and digestive system disorder.